ESC 365 - Changing the treatment paradigm of hyperkalaemia management to enable and optimise renin-angiotensin-aldosterone system inhibitor (RAASi) therapy.

Open Access

Changing the treatment paradigm of hyperkalaemia management to enable and optimise renin-angiotensin-aldosterone system inhibitor (RAASi) therapy.

Session: Hyperkalaemia and iron deficiency: how too much or too little may affect the heart

Topic: Heart failure, other

Speaker: Professor P. Van Der Meer (Groningen, NL)

Sponsored by Vifor Pharma

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Professor Peter Van Der Meer

University Medical Centre Groningen, Groningen (Netherlands (The))

57 presentations

4 followers

4 more presentations in this session

Introduction - Hyperkalaemia and iron deficiency: how too much or too little may affect the heart.

Speaker: Doctor J. Comin-Colet (Barcelona, ES)

Should iron be at the heart of concerns?

Speaker: Professor C. Lam (Singapore, SG)

Panel discussion and close - Hyperkalaemia and iron deficiency: how too much or too little may affect the heart.

Speaker: Doctor J. Comin-Colet (Barcelona, ES) Professor F. Ruschitzka (Zurich, CH)

Conclusion

Access the full session

Hyperkalaemia and iron deficiency: how too much or too little may affect the heart

Speakers: Professor P. Van Der Meer, Doctor J. Comin-Colet, Professor C. Lam, Doctor J. Comin-Colet, Professor F. Ruschitzka

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources